Rankings
▼
Calendar
APGE FY 2023 Earnings — Apogee Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
APGE
Apogee Therapeutics, Inc.
$4B
FY 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$93M
Net Income
-$84M
EPS (Diluted)
$-1.66
Cash Flow
Operating Cash Flow
-$75M
Free Cash Flow
-$75M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$401M
Total Liabilities
$21M
Stockholders' Equity
$380M
Cash & Equivalents
$118M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$93M
-$31M
-202.7%
Net Income
-$84M
-$40M
-111.1%
← Q4 2022
All Quarters
Q1 2023 →